Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The women's health initiative (WHI) provided convincing evidence that the use of estrogen plus progesterone (E+P) in postmenopausal women is associated with an increased risk of breast cancer.

Clinical Briefs By Louis Kuritzky, MD